Baumal Caroline
- SEC CIK
- 0001961100
In the past year, 3 open-market sale filings worth $175.2K and no purchases.
Current role at each company
- APLS Apellis Pharmaceuticals, Inc.Chief Medical Officeras of May 14, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $175.2K
- 3 filings
- Net
- −$175.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Baumal Caroline as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 (view filing) | Jan 22 | 1 day | Baumal CarolineChief Medical Officer | SSale | −2.80K | $21.77 | −$60.9K | −3.1%86.5K after | |
| Jan 21, 2026 (view filing) | Jan 20 | 1 day | Baumal CarolineChief Medical Officer | SSale | −1.88K | $19.79 | −$37.2K | −2.1%89.3K after | |
| Jan 6, 2026 (view filing) | Jan 5 | 1 day | Baumal CarolineChief Medical Officer | SSale | −3.02K | $25.53 | −$77.1K | −3.2%91.2K after | |
| Jan 21, 2025 (view filing) | Jan 17 | 4 days | Baumal CarolineChief Medical Officer | SSale | −1.85K | $29.96 | −$55.5K | −3.3%53.7K after | |
| Jan 8, 2025 (view filing) | Jan 6 | 2 days | Baumal CarolineChief Medical Officer | SSale | −2.82K | $33.81 | −$95.2K | −4.8%55.6K after | |
| Jan 5, 2024 (view filing) | Jan 4 | 1 day | Baumal CarolineChief Medical Officer | SSale | −2.75K | $60.05 | −$165.2K | −7.7%32.9K after |